Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 9

1.

Repression of alpha-synuclein expression and toxicity by microRNA-7.

Junn E, Lee KW, Jeong BS, Chan TW, Im JY, Mouradian MM.

Proc Natl Acad Sci U S A. 2009 Aug 4;106(31):13052-7. doi: 10.1073/pnas.0906277106. Epub 2009 Jul 23.

2.

MicroRNAs in Parkinson's disease.

Mouradian MM.

Neurobiol Dis. 2012 May;46(2):279-84. doi: 10.1016/j.nbd.2011.12.046. Epub 2012 Jan 5. Review.

PMID:
22245218
3.

Controlling the mass action of alpha-synuclein in Parkinson's disease.

Kim C, Lee SJ.

J Neurochem. 2008 Oct;107(2):303-16. doi: 10.1111/j.1471-4159.2008.05612.x. Epub 2008 Sep 2. Review.

4.

Viral vectors, animal models and new therapies for Parkinson's disease.

Schneider B, Zufferey R, Aebischer P.

Parkinsonism Relat Disord. 2008;14 Suppl 2:S169-71. doi: 10.1016/j.parkreldis.2008.04.024. Epub 2008 Jun 27. Review.

PMID:
18585946
5.

Neurotoxic conversion of beta-synuclein: a novel approach to generate a transgenic mouse model of synucleinopathies?

Fujita M, Sekigawa A, Sekiyama K, Sugama S, Hashimoto M.

J Neurol. 2009 Aug;256 Suppl 3:286-92. doi: 10.1007/s00415-009-5246-8. Review.

PMID:
19711118
6.

Pathological proteins in Parkinson's disease: focus on the proteasome.

Snyder H, Wolozin B.

J Mol Neurosci. 2004;24(3):425-42. Review.

PMID:
15655264
7.

Inhibitors of alpha-synuclein oligomerization and toxicity: a future therapeutic strategy for Parkinson's disease and related disorders.

Amer DA, Irvine GB, El-Agnaf OM.

Exp Brain Res. 2006 Aug;173(2):223-33. Epub 2006 May 30. Review.

PMID:
16733698
8.

α-Synuclein elevation in human neurodegenerative diseases: experimental, pathogenetic, and therapeutic implications.

Ulusoy A, Di Monte DA.

Mol Neurobiol. 2013 Apr;47(2):484-94. doi: 10.1007/s12035-012-8329-y. Epub 2012 Sep 4. Review.

PMID:
22944910
9.

α-Synuclein in Parkinson's disease.

Stefanis L.

Cold Spring Harb Perspect Med. 2012 Feb;2(2):a009399. doi: 10.1101/cshperspect.a009399. Review.

Items per page

Supplemental Content

Write to the Help Desk